Rab Prinjha
Director/Board Member bei Padlock Therapeutics, Inc.
Profil
Rab Prinjha is currently a Director at Padlock Therapeutics, Inc. He previously worked as the Head of Epigenetics Discovery Performance Unit at GSK Plc.
He obtained a doctorate degree from University College London.
Aktive Positionen von Rab Prinjha
Unternehmen | Position | Beginn |
---|---|---|
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Rab Prinjha
Unternehmen | Position | Ende |
---|---|---|
GSK PLC | Corporate Officer/Principal | - |
Ausbildung von Rab Prinjha
University College London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GSK PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Health Technology |